Nintedanib Accord
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nintedanib Accord, covering 2025-08-29 to 2026-06-25. Get the full timeline:
Most recent: EMA Authorised: Nintedanib Accord (nintedanib) — Accord Healthcare S.L.U.